ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Open access · hybridAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 59 citations in OpenAlex.
- Integrated ATAC-Seq and RNA-Seq Identify ATF3 as a Tumor Suppressor in UVB-Induced Keratinocyte Carcinogenesis.Biology · 2026Article
- Unraveling the molecular landscape: an overview on gene expression, epigenetic alterations, and therapeutic challenges in head and neck squamous cell carcinoma.Molecular genetics and genomics : MGG · 2026Review
- Apoptosis-inducing factor mitochondria-associated 2 (AIFM2)Journal of dental sciences · 2026Article
- Review
- MicroRNAs' Impact on Heart Diseases.International journal of molecular sciences · 2025Review
- Molecular profiling of head and neck squamous cell carcinomas in North-eastern Italy identifies possible tumour cell vulnerabilities.Translational oncology · 2025Article
- Challenging the Norm: The Unrecognized Impact of Soluble Guanylyl Cyclase Subunits in Cancer.International journal of molecular sciences · 2024Review
- Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.Scientific reports · 2024Article
- Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.Frontiers in cell and developmental biology · 2024Review
- Clinical and genomic characterization of chemoradiation-resistant HPV-positive oropharyngeal squamous cell carcinoma.Frontiers in oncology · 2024Article
- GREM1, LRPPRC and SLC39A4 as potential biomarkers of intervertebral disc degeneration: a bioinformatics analysis based on multiple microarray and single-cell sequencing data.BMC musculoskeletal disorders · 2023Article
- Novel Insights into the Molecular Mechanisms of Atherosclerosis.International journal of molecular sciences · 2023Review
- Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer.International journal of molecular sciences · 2023Article
- Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma.Frontiers in oncology · 2023Article
- Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer.Frontiers in oncology · 2023Article
- Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.Molecular biology reports · 2022Review
- A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82.Cancer communications (London, England) · 2021Article
- miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.EMBO molecular medicine · 2021Article
- MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies.Translational cancer research · 2021Review
- Overexpression of miRNA-9 enhances galectin-3 levels in oral cavity cancers.Molecular biology reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 6 institutions in 5 countries.
Francesca CitronDivision of Molecular Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Joshua ArmeniaDivision of Molecular Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Giovanni FranchinOncologic Radiotherapy, CRO Aviano, National Cancer Institute, Aviano, Italy.
Jerry PoleselCancer Epidemiology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Renato TalaminiCancer Epidemiology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Sara D'AndreaDivision of Molecular Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Sandro SulfaroDivision of Pathology, Azienda Ospedaliera Santa Maria degli Angeli, Pordenone, Italy.
Carlo M CroceDepartment of Cancer Biology and Genetics/CCC, The Ohio State University, Columbus, Ohio.
William KlementPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
David OtasekPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Chiara PastrelloPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Tomas TokarPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Igor JurisicaPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Deborah FrenchFaculty of Medicine and Psicology, Department of Clinical and molecular Medicine, University of Rome "La Sapienza," Santo Andrea Hospital, Rome, Italy.
Riccardo BombenClinical and Experimental Onco-Hematology Unit, CRO Aviano, National Cancer Institute, Aviano, Italy.
Emanuela VaccherMedical Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Diego SerrainoCancer Epidemiology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Barbara BellettiDivision of Molecular Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy.
Andrea VecchioneDepartment of Cancer Biology and Genetics/CCC, The Ohio State University, Columbus, Ohio. gbaldassarre@cro.it andrea.vecchione@uniroma1.it luigibarzan@libero.it.
Luigi BarzanDepartment of Surgery, CRO Aviano, National Cancer Institute, Aviano, Italy. gbaldassarre@cro.it andrea.vecchione@uniroma1.it luigibarzan@libero.it.
Gustavo BaldassarreDivision of Molecular Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy. gbaldassarre@cro.it andrea.vecchione@uniroma1.it luigibarzan@libero.it.
National Cancer Institute · UAPrincess Margaret Cancer Centre · CAAzienda Ospedaliera Sant'Andrea · ITAzienda Ospedaliera Santa Maria Degli Angeli · ITThe Ohio State University · USUniversity of Toronto · CA
Funding
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4MNCI NIH HHS R35 CA197706
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAnimalsBiomarkers, TumorCarcinoma, Squamous CellCell Line, TumorEpithelial-Mesenchymal TransitionFemaleGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansKeratin-13MaleMiceMicroRNAsMiddle AgedBiomarkers, TumorKeratin-13KRT13 protein, humanMicroRNAsMIR150, humanMIRN133 microRNA, humanMIRN1 microRNA, humanMIRN92 microRNA, humanSASH1 protein, humanSP1 protein, humanSp1 Transcription FactorTransforming Growth Factor betaTumor Suppressor Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.